Introduction {#s0001}
============

Schizophrenia is considered etiologically as a heterogeneous group of disorders.^[@CIT0001]^ Against this background of considerable heterogeneity, the presence of mental illness in close relatives (familial cases) versus no history of mental illness in close relatives (sporadic cases) has been considered in genetic studies.^[@CIT0002],[@CIT0003],[@CIT0004]^ This criterion represents one of the multiple strategies used to define a more homogeneous group of subjects.^[@CIT0005]^

It is difficult to ascertain familiality accurately, especially in outbred populations where families are largely mobile and historical data on multiple family members are scarce. However, despite the difficulties, it is a variable of fundamental importance in genetic studies, as already demonstrated. Specifically, significantly increased rates of *de novo* copy number variants have been reported in sporadic, as opposed to familial cases of schizophrenia,^[@CIT0001],[@CIT0004]^ and *de novo* single-nucleotide polymorphisms are also more common.^[@CIT0001]^ This provides evidence for an association on a genetic level, with at least some mutations enriched in sporadic cases.^[@CIT0001]^

Numerous attempts to parse the complicated, heterogeneous clinical presentation of schizophrenia into homogeneous groups that may be suitable for genetic research have taken place without much success. A number of clinical as well as environmental factors have been considered, such as gender, birth and perinatal insults, season of birth, early childhood pre-psychotic deviant behaviour, substance abuse, several comorbid conditions, specific clinical symptoms, age at the onset of primary illness^[@CIT0006]^ and suicidality,^[@CIT0007]^ amongst others.

Phenotype refinement has been beneficial in elucidating the genetic architecture of other neuropsychiatric disorders, such as Alzheimer's disease^[@CIT0008]^ and Parkinson's disease.^[@CIT0009]^ Gene identification efforts in schizophrenia may also benefit through the definition of more homogeneous phenotypes that allow a meaningful sub-grouping of individuals with the disease.^[@CIT0005]^

To our knowledge, a phenotype using a familial versus sporadic sub-grouping has not been characterised. The aim of this study was to use this sub-grouping to determine a more homogeneous phenotype for genetic research via comparison of various clinical, socio-demographic as well as environmental variables in familial versus sporadic schizophrenia.

Methods {#s0002}
=======

Study design and participants {#s20003}
-----------------------------

This study included participants from the collaborative study on Genetics of Schizophrenia led by Dr Karayiorgou since 1997.^[@CIT0010]^ Participants were drawn from the Afrikaner founder population in South Africa and were initially recruited from inpatient, outpatient and follow-up clinics at Weskoppies Hospital in Pretoria. Previous work has shown that the Afrikaner sample is clinically comparable to samples recruited from outbred populations, including the United States.^[@CIT0010]^ The Afrikaner sample, however, being derived from a founder population, offers additional advantages for mapping genes caused by reduced genetic heterogeneity and a more uniform environment.^[@CIT0010]^ The close-knit nature of Afrikaner families and the presence of long-term care mental health facilities in the country allow for a relatively reliable ascertainment of family history of mental illness and subsequent distinction between sporadic and familial groups.

This study made use of a cross-sectional observational design. We used data from the database that has been assembled for the ongoing genetic research on this population. The database contains detailed information obtained by administering in-person the Diagnostic Interview for Genetic Studies (DIGS) to all subjects, medical intake forms, questionnaires on early development, family history, medication history, as well as information derived from witnesses and medical records when necessary.^[@CIT0010]^ From this extensive database, we selected a subsample of 384 participants for this study. Our criteria for this selection were: (1) subjects met full Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for schizophrenia or schizoaffective disorder (as determined by the DIGS, which in multi-site test--retest analyses have been found to be reliable for the major DSM diagnostic categories^[@CIT0011]^), and (2) subjects in whom family history of schizophrenia or schizoaffective disorder had been ascertained and was available. Any subject with a first-degree, second-degree or third-degree relative diagnosed with schizophrenia or schizoaffective disorder was considered as a familial case for the analyses presented here.

Measurements {#s20004}
------------

All data recorded upon the initial recruitment of subjects, as well as any available follow-up data, were reviewed and captured using a data capturing sheet. We assessed basic socio-demographic variables, such as gender, month of birth (grouped to reflect seasonality, with July to September representing the peak months for winter or spring births in the southern hemisphere, previously associated with schizophrenia risk),^[@CIT0012]^ marital status, employment status and the highest level of education.

We also assessed several clinical variables, including age at onset of the primary psychiatric diagnosis (defined as the age when full DSM criteria were first met), suicide ideation and number of suicide attempts, as well as the presence of comorbid diagnoses. Amongst the comorbidities, we considered the presence of intellectual disability (ID) or borderline ID, obsessive compulsive disorder or symptoms, major depressive disorder, alcohol abuse, cannabis abuse or use of more than one illicit substance. An illicit substance was defined as any substance with abuse potential and not legal under South African law. Notable legal substances include tobacco and alcohol, with cannabis defined as an illegal substance under current legislation. Several individual clinical symptoms were also considered. These included delusions, hallucinations (captured in three sub-categories of visual, auditory and other sensory hallucinations), disorganised behaviour, disordered thought and alogia.

Information about history of early childhood, pre-psychotic and deviant behaviour before the age of 10, which has been previously linked to the development of schizophrenia,^[@CIT0013]^ was also obtained from the database where available. The following seven early deviant behaviours were captured and analysed: social difficulties, extreme aggression, odd behaviour, extreme fears, chronic sadness, learning disability and impairment in attention.^[@CIT0014]^

Finally, birth and perinatal insults were also considered.

Data analysis {#s20005}
-------------

Logit models were fitted to test whether there is a relationship between a binary outcome variable and covariates of interest (differential family history, sex and primary diagnosis). Patients for whom the response to the outcome variable was unknown were excluded from the analysis. The binary outcome variables considered in the different models were comorbid diagnosis, cannabis use, illicit substance abuse, a patient being single, perinatal insults, hallucinations, early deviant behaviour and suicidality. Descriptive data is provided in [Table 1](#T0001){ref-type="table"}. A backward elimination procedure was used, and only covariates with a *p* \> 0.15 were retained in the model. In the reporting of results, *p*-values were given for relationships with *p* \< 0.05 and estimates of odds ratios together with 95% confidence intervals (95% CI). Where more than one covariate was retained in the model, the *p*-value for the overall model based on the Wald chi-square test statistic was also given.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Variable             Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N*= 18)                                           
  -------------------- -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ----------------------------------------- ------- ------- ------- ------- ------- ------
  Age at recruitment   35.21                      13.89                      31.16                                   9.84                                    38.00                                      12.83                                     31.77   10.39   35.48   13.44   29.56   9.24

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Variable                       Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                     
  ------------------------------ -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ ------- ---- ------- ---- ------- ----
  Male                           59.73                      89                         70.77                                   92                                      54.55                                      24                                         59.09   13   61.9    13   61.11   11
  Single (Never married)         69.13                      103                        75.38                                   98                                      45.45                                      20                                         68.18   15   61.90   13   66.67   12
  Employed                       82.55                      123                        82.31                                   107                                     68.18                                      30                                         63.64   14   47.62   10   72.22   13
  Completed Grade 12             44.30                      66                         64.62                                   84                                      68.18                                      30                                         86.36   19   66.67   14   66.67   12
  Completed tertiary education   12.75                      19                         12.31                                   16                                      25.00                                      11                                         18.18   4    19.05   4    27.78   5

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Syndrome features                Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                         
  -------------------------------- -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ ------- ------ ------- ------ ------- ------
  Age of primary diagnosis onset   22.49                      7.45                       23.29                                   6.66                                    25.07                                      8.06                                       20.18   3.54   24.62   7.48   21.72   5.38

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Co-morbid diagnosis                  Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                    
  ------------------------------------ -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ ------- --- ------- ---- ------- ---
  Intellectual disability              6.04                       9                          3.85                                    5                                       0.00                                       0                                          0.00    0   0.00    0    0.00    0
  Borderline intellectual disability   8.05                       12                         3.85                                    5                                       4.55                                       2                                          0.00    0   0.00    0    0.00    0
  Obsessive compulsive disorder        4.70                       7                          6.15                                    8                                       0.00                                       0                                          9.09    2   19.05   4    16.67   3
  Obsessive compulsive symptoms        4.03                       6                          6.15                                    8                                       2.27                                       1                                          4.55    1   9.52    2    0.00    0
  Major depressive disorder            10.07                      15                         9.23                                    12                                      15.91                                      7                                          9.09    2   19.05   4    27.78   5
  Social phobia                        2.01                       3                          0.00                                    0                                       0.00                                       0                                          4.55    1   4.76    1    11.11   2
  Alcohol abuse                        12.08                      18                         13.08                                   17                                      25.00                                      11                                         9.09    2   19.05   4    33.33   6
  Cannabis abuse                       34.23                      51                         35.38                                   46                                      27.27                                      12                                         36.36   8   66.67   14   44.44   8
  \> 1 illicit substance used before   10.07                      15                         12.31                                   16                                      11.36                                      5                                          9.09    2   4.76    1    27.78   5

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Deviant behavior \< age 10               Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                            
  ---------------------------------------- -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ ------- ------- -------- ------- ------- -------
  Social difficulties                      55.28                      68/123                     44.25                                   50/113                                  50.00                                      18/36                                      33.33   7/21    66.67    12/18   64.71   11/17
  Extreme aggression                       9.40                       11/117                     6.25                                    7/112                                   11.43                                      4/35                                       9.52    2/21    0.00     0/16    5.88    1/17
  Odd behavior                             16.95                      20/118                     9.91                                    11/111                                  5.71                                       2/35                                       28.57   6/21    18.75    3/16    11.76   2/17
  Extreme fears                            24.58                      29/118                     25.89                                   29/112                                  31.43                                      11/35                                      19.05   4/21    56.25    9/16    41.18   7/17
  Chronic sadness                          11.11                      13/117                     9.09                                    10/110                                  20.00                                      7/35                                       9.52    2/21    31.25    5/16    23.53   4/17
  Learning disability                      36.97                      44/119                     28.57                                   32/112                                  20.00                                      7/35                                       14.29   3/21    31.25    5/16    35.29   6/17
  Impairment in attention                  59.83                      70/117                     49.56                                   56/113                                  37.14                                      13/35                                      38.10   8/21    68.75    11/16   58.82   10/17
  Presence of any early deviant behavior   83.33                      105/126                    71.93                                   82/114                                  75.00                                      27/36                                      71.43   15/21   100.00   18/18   82.35   14/17

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Variable                            Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                  
  ----------------------------------- -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ ------ ---- ------ ---- ------ ----
  Number of early deviant behaviors   2.09                       117                        1.68                                    110                                     1.74                                       35                                         1.52   21   2.69   16   2.41   17

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Symptom history           Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                              
  ------------------------- -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ -------- ------- -------- ------- -------- -------
  Delusions                 98.62                      143/145                    98.46                                   128/130                                 100.00                                     44/44                                      100.00   22/22   100.00   20/20   100.00   18/18
  Hallucinations            94.93                      131/138                    83.90                                   99/118                                  77.50                                      31/40                                      95.45    21/22   84.21    16/19   88.24    15/17
  Auditory hallucinations   90.15                      119/132                    80.00                                   92/115                                  71.79                                      28/39                                      77.27    17/22   78.95    15/19   76.47    13/17
  Visual hallucinations     35.43                      45/127                     36.36                                   40/110                                  30.56                                      11/36                                      50.00    11/22   31.58    6/19    17.65    3/17
  Sensory hallucinations    30.16                      38/126                     17.27                                   19/110                                  20.59                                      7/34                                       23.81    5/21    27.78    5/18    5.88     1/17
  Disorganized behavior     78.99                      94/119                     84.11                                   90/107                                  84.38                                      27/32                                      90.48    19/21   76.47    13/17   76.92    10/13
  Disordered thought        73.68                      84/114                     74.31                                   81/109                                  77.14                                      27/35                                      85.00    17/20   94.12    16/17   64.29    9/14
  Alogia                    41.44                      46/111                     56.73                                   59/104                                  45.45                                      15/33                                      60.00    12/20   94.74    18/19   71.43    10/14

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

###### 

Demographic & clinical characteristics of 214 familial and 170 sporadic participants with a DSM diagnosis of schizophrenia or schizoaffective disorder.

  Other                         Familial SCZ (*N* = 149)   Sporadic SCZ (*N* = 130)   Familial SAD, bipolar type (*N* = 44)   Sporadic SAD, bipolar type (*N* = 22)   Familial SAD, depressive type (*N* = 21)   Sporadic SAD, depressive type (*N* = 18)                                         
  ----------------------------- -------------------------- -------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------ ------- ------ ------- ------ ------- ------
  Suicidal ideation             8.78                       13/148                     9.30                                    12/129                                  18.18                                      8/44                                       9.09    2/22   28.57   6/21   22.22   4/18
  Suicide attempts              22.97                      34/148                     16.28                                   21/129                                  25.00                                      11/44                                      36.36   8/22   28.57   6/21   33.33   6/18
  Birth and perinatal insults   39.05                      41/105                     41.44                                   46/111                                  27.03                                      10/37                                      33.33   7/21   38.89   7/18   30.77   4/13
  Winter/spring birth           24.16                      36/149                     23.85                                   31/130                                  15.91                                      7/44                                       27.27   6/22   33.33   7/21   11.11   2/18

SCZ, schizophrenia; SAD, schizoaffective disorder; *N*, total number of subjects in a group; *N~c~*, number of subjects in a group for whom the covariate was known; *n*, number of subjects who were positive for a particular covariate; SD, standard deviation.

Two main logit models were considered to account for the large differences in group sizes of primary diagnosis. In the first model (results given in [Table 1-A1](#T0002){ref-type="table"}), the primary diagnosis entered into the model was schizophrenia and schizoaffective disorder (bipolar and depressive types combined) and in the second model (results in [Table 2-A1](#T0003){ref-type="table"}) only schizoaffective disorder was considered and entered as bipolar or depressive. As there are two models for each binary outcome, a Bonferroni correction should be made by comparing the *p*-values given in the table with 0.025 instead of 0.05. General linear models (GLM) were fitted to determine whether any of the covariates (same as for the logit model) are significantly related to the mean age at onset. The normality assumption was validated and Least Squares Mean (LSMeans) was calculated to adjust for the effect of other covariates in the model and differences in group sizes. The results are given in [Table 3-A1](#T0004){ref-type="table"}, and because there are three models, a Bonferroni correction should be made by comparing *p*-values given with 0.05/3 = 0.0167. [Tables 1-A1](#T0002){ref-type="table"}, [2-A1](#T0003){ref-type="table"} and [3-A1](#T0004){ref-type="table"} are included in [Appendix 1](#app001){ref-type="app"}.

Ethical considerations {#s20006}
----------------------

Consent for the use of information in the future studies was obtained during the initial recruitment. The study protocol was submitted to Master of Medicine (MMed) and Research Ethics Committees of the Faculty of Health Sciences of the University of Pretoria. Written approval was obtained from both committees (Approval number 291/2016).

Results {#s20007}
-------

Of the 384 participants, 279 (73%) had a diagnosis of schizophrenia, 66 (17%) had a diagnosis of schizoaffective disorder, bipolar type, and 39 (10%) had a diagnosis of schizoaffective disorder, depressive type; 242 (63%) were male and 142 (37%) were female participants. The mean age at onset of the primary diagnosis was 23 years (standard deviation \[SD\] = 7); 238 (62%) participants had at least one comorbid diagnosis; 45 participants (12%) had suicidal ideation and 86 (22%) had suicide attempts; 115 participants (38%) had birth or perinatal complications; 89 (23%) were born in the winter or spring months (July to September in the southern hemisphere); and 261 participants (79%) had one or more of the seven early childhood deviant behaviours that were assessed. Specifically, 166 participants (51%) had early social difficulties: 25 (8%) had extreme aggression, 44 (14%) had odd behaviour, 89 (28%) had extreme fears, 41 (13%) had chronic sadness, 97 (30%) had a learning disability and 168 (53%) had impairment in attention.

Initial comparisons across the sample, controlling for familiality and diagnosis, mainly identified some gender differences. In the combined schizophrenia and schizoaffective group, when controlling for diagnosis, the odds of being a male subject and single was four times higher compared to female participants (95% confidence interval \[CI\] = 2.5, 6.3; *p* \< 0.0001), an association driven mostly by the schizoaffective disorder bipolar type group, where the corresponding odds ratio was 4.6 (95% CI = 2.0, 10.8; *p* = 0.0004). Another difference in the combined schizophrenia and schizoaffective group was that male participants had higher odds for a comorbid diagnosis than female participants (2.97 \[95% CI = 1.9, 4.6; *p* \< 0.0001\]) and were also more likely to have abused cannabis than female participants (5.8 \[95% CI = 3.3, 10.2; *p* \< 0.0001\]). This association held true when prior abuse of any substance (not just cannabis) was considered (5.2 \[95% CI = 3.1, 8.6; *p* \< 0.0001\]).

We then focused on familiality in the logit models and controlled for sex and diagnosis.

[Table 1](#T0001){ref-type="table"} shows the descriptive statistics of the three diagnostic groups subdivided into familial and sporadic cases. The table contains information on basic socio-demographic variables, age of primary diagnosis onset, comorbid diagnoses, early childhood deviant behaviours, clinical symptoms history, suicidal ideation or attempts, birth and perinatal insults, as well as season (month) of birth.

From a general linear model, the mean age at onset for sporadic schizophrenia versus familial schizophrenia when controlling for sex did not differ significantly (23.7 vs. 22.7; *p* = 0.23). The adjusted or LSMeans that was calculated also accounted for differences in group sizes. The same was true for schizoaffective disorder, depressive type (22.1 vs. 25.0; *p* = 0.17). However, there was a statistically significant difference in schizoaffective disorder bipolar type, where disease onset was at 20.6 years of age in sporadic cases versus 25.3 years of age in familial cases (*p* = 0.0077, effect size *η*^[@CIT0002]^ = 0.23). The difference was also gender-dependent (20.4 for male participants and 25.5 for female participants, *p* = 0.0022).

No statistically significant differences were identified regarding familiality and being single.

There were no differences between sporadic and familial cases with regard to the presence of a comorbid diagnosis in any of the diagnostic groups.

There were no statistically significant differences when comparing birth and perinatal insults based on familiality.

In the combined schizophrenia and schizoaffective disorder group, the odds for the presence of any early deviant behaviour was 1.9 times higher in the familial compared to the sporadic group (95% CI = 1.1, 3.3, *p* = 0.0167) when controlling for sex (Wald chi-square statistic for overall model *p* = 0.02).

Suicidal ideation and suicide attempts were significantly higher (2.3 times) in the schizoaffective disorder group compared to the schizophrenia group (95% CI = 1.5, 3.7, *p* = 0.0003), but there was no significant difference based on familiality.

Frequencies for the month of birth were higher in March, April, May, July, September and October in the familial group, and higher in June in the sporadic group. Further analysis did not yield significant results regarding the season of birth.

Discussion {#s0008}
==========

We attempted to delineate a more homogeneous phenotype for genetic research via a comparison of various socio-demographic and clinical variables in an adult population with a lifetime diagnosis of schizophrenia or schizoaffective disorder. The main comparative variable was familiality, as this could have significant discriminatory value in genetic studies. Our subjects were drawn from the Afrikaner population in South Africa, where determination of familiality could be carried out relatively accurately given the close-knit family structure, restricted population movement and wide availability of family medical records in long-term mental health facilities.

Our findings demonstrated that the combined schizophrenia and schizoaffective disorder group did not differ significantly on most of the covariates that we compared between the sporadic and familial groups. These included marital status, clinical symptomatology, comorbidities, birth and perinatal insults, suicidality and season of birth. The only variable that differed was the early childhood deviant behaviour, previously linked to the later development of schizophrenia,^[@CIT0013]^ which we found to be more common in the familial group. This could make sense from a genetic point of view where familial predisposition could lead to early manifestations of an illness. Early deviant behaviour was not, however, associated with lower age at onset.

When considering the schizoaffective group, we found that the age at onset in the bipolar type of the schizoaffective diagnosis was significantly lower in the sporadic group. Age at onset has been associated with increased genetic loading.^[@CIT0015]^ It is also one of the most frequently studied outcome predictors in schizophrenia. A recent meta-analysis found a statistically significant association between lower age at onset and higher rates of hospitalisation, relapses and negative symptoms. It was also associated with worse social or occupational functioning and worse global outcome.^[@CIT0016]^ Our study did not specifically look at the number of hospitalisations, relapses, social or occupation functioning or global outcomes in any of the groups.

Limitations {#s0009}
===========

The study has some limitations. The subjects in the study were all Caucasian of European descent (Afrikaner), and the findings may therefore not be applicable to other races. Although appropriate statistical corrections were made, the diagnostic, gender and familial--sporadic groups were not equally represented. The duration of illness may have also influenced severity and thus presentation at recruitment. The database of information was not complete for all the covariates that were assessed.

The size of the schizoaffective disorder subset also limited the analyses that could be performed. Accurate recording of family history was challenging, and although it was much more accurate in the Afrikaner, and perhaps other founder populations, than outbred populations, there might still be some errors.

Conclusion {#s0010}
==========

The sporadic bipolar type of the schizoaffective diagnosis seems to form a more homogeneous group with lower age at onset. The age at onset has prognostic value with a possible genetic origin. An earlier age at onset has also been linked to a higher genetic load in Alzheimer's disease, systemic lupus erythematosus and cancer.^[@CIT0001]^

In addition to this study, genetic linkage analysis also appears to support a relatively specific genetic component in schizoaffective disorder.^[@CIT0003]^ Specifically, we have previously shown that a genetic linkage to the *13q locus* was 4.16 times more common in schizoaffective disorder compared with linkage to the *1p locus*.^[@CIT0017]^

Therefore, the sporadic bipolar type of the schizoaffective diagnosis may be helpful in elucidating the genetic complexity of schizophrenia and should be studied as a separate diagnostic entity in genetic studies.

Unfortunately, there is low diagnostic reliability for the schizoaffective disorder diagnosis^[@CIT0018]^ and, in particular, the distinction between the bipolar and the depressive types. Equally challenging is the accurate assessment of the sporadic versus the familial nature of psychiatric illness. Founder populations offer certain advantages on that front.

Given these results, it appears that the efforts required for both correct diagnostic assessments and family history assessments are warranted, as the bipolar type of the schizoaffective diagnosis in its sporadic form is a clinical entity with potential utility in genetic research.
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 {#s0016}

###### 

Logit models where predictors entered are differential family history, sex, diagnosis (schizophrenia or schizoaffective disorder).

  Binary outcome            Analysis of maximum likelihood estimates   Odds ratio estimates   Global null hypothesis                                                                                                  
  ------------------------- ------------------------------------------ ---------------------- ------------------------ --------- ----------- -------------- ------- -------- -------- --------- --------- ----------- -----------
  Comorbid diagnosis        Intercept                                  1                      0.3748                   0.1103    11.5531     0.0007         \-      \-       \-       24.3535   1         \< 0.0001   
  Sex                       1                                          0.5442                 0.1103                   24.3535   \< 0.0001   M vs. F        2.970   1.927    4.575    \-        \-        \-          
  Cannabis use              Intercept                                  1                      −1.0476                  0.1416    54.7062     \< 0.0001      \-      \-       \-       \-        38.7720   1           \< 0.0001
  Sex                       1                                          0.8819                 0.1416                   38.7720   \< 0.0001   M vs. F        5.835   3.349    10.166   \-        \-        \-          
  Illicit substance abuse   Intercept                                  1                      −0.7715                  0.1291    35.7053     \< 0.0001      \-      \-       \-       \-        40.4437   1           \< 0.0001
  Sex                       1                                          0.8211                 0.1291                   40.4437   \< 0.0001   M vs. F        5.166   3.114    8.570    \-        \-        \-          
  Single                    Intercept                                  1                      0.5161                   0.1260    16.7703     \< 0.0001      \-      \-       \-       \-        41.0772   2           \< 0.0001
  Sex                       1                                          0.6951                 0.1166                   35.5317   \< 0.0001   M vs. F        4.015   2.542    6.342    \-        \-        \-          
  Diagnosis                 1                                          −0.3148                0.1258                   6.2595    0.0124      SCZ vs. SAD    1.876   1.145    3.077    \-        \-        \-          
  Perinatal insults         Intercept                                  1                      −0.5772                  0.1260    20.9828     \< 0.0001      \-      \-       \-       \-        4.0357    1           0.0445
  Sex                       1                                          0.2531                 0.1260                   4.0357    0.0445      M vs. F        1.659   1.012    2.719    \-        \-        \-          
  Hallucinations            Model not significant                                                                                                                                                                     
  Early deviant behavior    Intercept                                  1                      1.2534                   0.1378    82.6978     \< 0.0001              7.6209   2        0.0221                          
  DFH                       1                                          0.3274                 0.1368                   5.7262    0.0167      Fam vs. Spor   1.925   1.126    3.290    \-        \-        \-          
  Sex                       1                                          0.2249                 0.1383                   2.6439    0.1039      \-             \-      \-       \-       \-        \-        \-          
  Suicidality               Intercept                                  1                      −0.4791                  0.118     16.4865     \< 0.0001      \-      \-       \-       \-        12.7885   1           0.0003
  Diagnosis                 1                                          0.4220                 0.118                    12.7885   0.0003      SAD vs. SCZ    2.326   1.464    3.694    \-        \-        \-          

DFH, differential family history; DF, degrees of freedom; Est, parameter estimate; SE, standard error; Wald, Wald chi-square statistic; OR, odds ratio; M, male; F, female; SCZ, schizophrenia; SAD, schizoaffective disorder.

###### 

Logit models where predictors entered are DFH, sex, schizoaffective disorder (bipolar or depressive).

  Binary outcome            Analysis of maximum likelihood estimates   Odds ratio estimates   Global null hypothesis                                                                                          
  ------------------------- ------------------------------------------ ---------------------- ------------------------ -------- --------- ----------- ------------- ------- -------- -------- ---------- ---- --------
  Comorbid diagnosis        Intercept                                  1                      0.4039                   0.2192   3.3957    0.0654      \-            \-      \-       \-       7.6387     2    0.0219
  Sex                       1                                          0.4821                 0.2075                   5.3993   0.0201    M vs. F     2.623         1.163   5.915    \-       \-         \-   
  SAD (b or d)              1                                          −0.3361                0.2185                   2.3669   0.1239    \-          \-            \-      \-       \-       \-         \-   
  Cannabis use              Intercept                                  1                      −1.0088                  0.2585   15.2269   \< 0.0001   \-            \-      \-       \-       11.2095    2    0.0037
  DFH                       1                                          0.3732                 0.2288                   2.6597   0.1029    M vs. F     4.786         1.739   13.172   \-       \-         \-   
  Sex                       1                                          0.7829                 0.2583                   9.1884   0.0024    \-          \-            \-      \-       \-       \-         \-   
  Illicit substance abuse   Intercept 1                                1                      −0.4183                  0.2227   3.5271    0.0604      \-            \-      \-       \-        10.3389   2    0.0057
  DFH                       1                                          −0.3987                0.2147                   3.4488   0.0633    M vs. F     3.371         1.421   7.997    \-       \-         \-   
  Sex                       1                                           0.6076                0.2203                   7.6052   0.0058    \-          \-            \-      \-       \-       \-         \-   
  Single                    Intercept                                  1                      0.2941                   0.2243   1.7185    0.1899      \-            \-      \-       \-       14.3893    2    0.0008
  DFH                       1                                          −0.3754                0.2249                   2.7856   0.0951    M vs. F     4.641         1.990   10.823   \-       \-         \-   
  Sex                       1                                          0.7674                 0.2160                   12.619   0.0004    M vs. F     3.789         1.349   10.643   \-       \-         \-   
  Perinatal insults         Intercept                                  1                      −0.9762                  0.2635   13.7255   0.0002      \-            \-      \-       \-       6.3893     1    0.0115
  Sex                       1                                          0.6660                 0.2635                   6.3893   0.0115    \-          \-            \-      \-       \-       \-         \-   
  Hallucinations            Intercept                                  1                      −1.5785                  0.2977   28.1059   \< 0.0001   Fam vs. Spo   3.446   1.073    11.072   4.3178     1    0.0377
  DFH                       1                                          0.6187                 0.2977                   4.3178   0.0377    \-          \-            \-      \-       \-       \-         \-   
  Early deviant behavior    Intercept                                  1                      1.6983                   0.3373   25.3551   \< 0.0001   \-            \-      \-       \-       3.9304     1    0.0474
  SAD (b or d)              1                                          −0.6686                0.3373                   3.9304   0.0474    D vs. B     3.802         1.015   14.286   \-       \-         \-   

DFH, differential family history ; DF, degrees of freedom; Est, parameter estimate; SE, standard error; Wald, Wald chi-square statistic; OR, odds ratio; SAD (b or d), schizoaffective disorder (bipolar or depressive); M, male; F, female.

Note: Suicidality, model not significant.

###### 

General linear models for different diagnosis; age at onset as outcome variable and predictors entered are differential family history and sex.

  Diagnosis                                  Analysis of maximum likelihood estimates   LSMeans                                                                            
  ------------------------------------------ ------------------------------------------ --------- -------- -------- ----------- ---------- -------- -------- ------ ------ --------
  Schizophrenia                              Intercept                                  24.7081   0.8818   28.02    \< 0.0001   Familial   22.7     0.2302   Male   22.7   0.0252
  DFH                                        0.4821                                     0.2075    −1.20    0.2302   Sporadic    23.7       \-       Female   24.2   \-     
  Sex                                        −0.3361                                    0.2185    −2.25    0.0252   \-          \-         \-       \-       \-     \-     
  Schizoaffective disorder bipolar type      Intercept                                  23.2042   1.6738   13.86    \< 0.0001   Familial   25.3     \-       Male   20.4   0.0022
  DFH                                        4.6539                                     1.6904    2.75     0.0077   Sporadic    20.6       0.0077   Female   25.5   \-     
  Sex                                        −5.1148                                    1.6056    −3.19    0.0022   \-          \-         \-       \-       \-     \-     
  Schizoaffective disorder depressive type   Intercept                                  23.5755   2.0172   11.69    \< 0.0001   Familial   25.0     0.1710   Male   22.0   0.1656
  DFH                                        2.9209                                     2.0911    1.40     0.1710   Sporadic    22.1       \-       Female   25.0   \-     
  Sex                                        −3.0327                                    2.1428    −1.42    0.1656   \-          \-         \-       \-       \-     \-     

DFH, differential family history; DF, degrees of freedom; Est, parameter estimate; SE, standard error; LSMeans, least squares means.
